Evidence map›Paper›PMID 35530269›Full record

ArticleAmerican journal of cancer research2022

Integrative immunogenomic analysis reveals transcriptional and immune-related differences in hepatocellular carcinoma patients with different disease-free survival.

Xueling Yang, Guanglin Lei, Junxiao Wang, Zhenyu Wen, Zhenhu Ma, Yun Zhao, Hui Ren, Hui Xie

Open access · greenAbstract read
PubMed Full text at PMC
In one paragraph

Article in American journal of cancer research, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact, top 85% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 0 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 1 country.

Xueling YangDepartment of Interventional Therapy, Tianjin Medical University Cancer Institute & Hospital, National Clinical Research Center for Cancer, Tianjin's Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy Tianjin 300060, China.
Guanglin LeiFifth Medical Center of Chinese PLA General Hospital Beijing 100039, China.
Junxiao WangDepartment of Occupational and Environmental Health, School of Public Health, Jilin University Changchun 130000, Jilin, China.
Zhenyu WenDepartment of Occupational and Environmental Health, School of Public Health, Jilin University Changchun 130000, Jilin, China.
Zhenhu MaFifth Medical Center of Chinese PLA General Hospital Beijing 100039, China.
Yun ZhaoFifth Medical Center of Chinese PLA General Hospital Beijing 100039, China.
Hui RenFifth Medical Center of Chinese PLA General Hospital Beijing 100039, China.
Hui XieFifth Medical Center of Chinese PLA General Hospital Beijing 100039, China.
Chinese PLA General Hospital · CNJilin University · CNTianjin Medical University Cancer Institute and Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

A comprehensive investigation of the neoantigen spectrum and immune infiltration in patients with hepatocellular carcinoma (HCC) is lacking. This study aimed to examine the molecular features correlating with better prognoses in HCC patients. 27 paired tumor and normal tissues from 27 HCC patients were collected and performed with whole-exome sequencing. The most frequently mutated gene in 27 HCC patients was

Indexed as

Hepatocellular carcinoma (HCC)immuneintegrated multiomics analysisneoantigen

Identifiers

PMID35530269
PMCPMC9077058
OpenAlexW4285740001

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.